Recent Finacing
Recent Raise
bYoRNA develops a patented bioproduction platform that uses genetically modified yeast to manufacture therapeutic mRNA with reduced immunogenicity for oncology, rare diseases, and gene therapy applications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at bYoRNA.
